EP 1303281 A1 20030423 - METHODS OF TREATMENT
Title (en)
METHODS OF TREATMENT
Title (de)
VERFAHREN ZUR BEHANDLUNG
Title (fr)
METHODES DE TRAITEMENT
Publication
Application
Priority
- US 0112386 W 20010417
- US 19771700 P 20000418
Abstract (en)
[origin: WO0178734A1] The present invention provides methods which use 4-amino-azepan-3-one protease inhibitors of cathepsin L in the treatment of diseases in which cathepsin L is implicated, especially treatment or prevention of rheumatoid arthritis; treatment or preventio nof cancer metastasis; treatment or preventio of diseases requiring inhibition of tissue destruction by macrophage, particularly lung macrophage, such as asthma, chronic obstructive pulmonary disease (COPD), and emphysema; treatment or preventoin of diseases requiring, for therapy, inhibition of positive selection of CD4<+>T<-> cells by cortical thymic epithelial cells.
IPC 1-7
IPC 8 full level
A61K 31/44 (2006.01); A61K 31/55 (2006.01); A61P 11/00 (2006.01); A61P 11/06 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 35/04 (2006.01); A61P 43/00 (2006.01); C07D 401/12 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01)
CPC (source: EP)
A61K 31/55 (2013.01); A61P 11/00 (2017.12); A61P 11/06 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 35/04 (2017.12); A61P 43/00 (2017.12)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 0178734 A1 20011025; AU 5356001 A 20011030; CO 5280093 A1 20030530; EP 1303281 A1 20030423; EP 1303281 A4 20060215; JP 2003531122 A 20031021
DOCDB simple family (application)
US 0112386 W 20010417; AU 5356001 A 20010417; CO 01029288 A 20010416; EP 01927076 A 20010417; JP 2001576034 A 20010417